Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
IDH3G - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
BOLA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BID - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LPGAT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CNOT9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SAE1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRPF31 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IRF2BP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NME7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RABGAP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
COPA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PARM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KIFAP3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZFAND2A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SYNJ2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EIF3B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARL4A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TNIP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LAPTM4B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PHPT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on